Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NKTX	NKARTA INC	$133.54M	-27.70%	-22.20%	-25.13%	-21.80%	0.26	15.24	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.77B	-160.60%	-49.60%	-64.57%	-38.50%	3.78	4.64	95.40%	-279.30%	-253.32%
FBRX	FORTE BIOSCIENCES INC	$267.70M	-75.60%	-65.90%	-61.53%	-3,473.20%	0.15	7.34	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$211.96M	-28.70%	-21.10%	-32.68%	-220.10%	0.26	7.86	100.00%	-68.30%	-83.92%
OCUL	OCULAR THERAPEUTIX INC	$3.10B	-87.20%	-57.90%	-65.70%	-252.50%	0.59	7.85	88.90%	-447.60%	-425.87%
BLTE	BELITE BIO INC	$4.50B	N/A	N/A	N/A	N/A	0.03	34.37	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$148.66M	-1,042.80%	-565.50%	-891.35%	1,235.40%	0.74	2.35	N/A	N/A	N/A
ATAI	ATAI BECKLEY NV	$1.56B	-107.90%	-78.60%	-68.03%	-104.70%	0.50	7.90	100.00%	-5,109.10%	-5,032.77%
NGNE	NEUROGENE INC	$324.05M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$4.79B	-35.10%	-32.00%	-37.71%	-36.00%	0.12	15.12	100.00%	-27,563.30%	-27,563.32%
CRSP	CRISPR THERAPEUTICS AG	$5.40B	-26.40%	-22.50%	-22.79%	-24.00%	0.17	16.22	100.00%	-1,273.70%	-1,263.99%
NVAX	NOVAVAX INC	$1.07B	-167.00%	25.50%	50.00%	71.10%	-8.53	2.27	91.80%	32.10%	35.22%
MBX	MBX BIOSCIENCES INC	$1.34B	-29.30%	-28.10%	-20.75%	-42.40%	0.03	32.96	N/A	N/A	N/A
AVXL	ANAVEX LIFE SCIENCES CORP	$359.18M	-46.80%	-41.50%	-48.89%	423.70%	0.09	11.61	N/A	N/A	N/A
RNXT	RENOVORX INC	$35.18M	-122.20%	-90.70%	-123.25%	3,053.60%	0.39	5.83	67.80%	-1,196.70%	-1,238.04%
PHIO	PHIO PHARMACEUTICALS CORP	$12.06M	-86.40%	-75.80%	-80.83%	960.20%	0.17	6.90	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$95.55M	-30.90%	-29.60%	-36.12%	8,256.50%	0.08	13.10	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$79.70M	-138.90%	-96.70%	-193.39%	-132.10%	0.85	2.40	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$165.89M	-76.00%	-52.30%	-66.92%	-1,029.20%	0.94	12.89	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$423.47M	-26.40%	-22.10%	-26.87%	-25.40%	0.21	14.08	100.00%	-168.20%	-169.85%
NRSN	NEUROSENSE THERAPEUTICS LTD	$21.90M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
CLRB	CELLECTAR BIOSCIENCES INC	$15.35M	-205.90%	-108.00%	-193.36%	491.60%	0.66	2.77	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$1.37B	-120.60%	-53.80%	-58.61%	-127.50%	1.23	4.56	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$219.95M	-35.10%	-32.50%	-39.27%	-63.70%	0.09	13.69	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$2.27B	-41.50%	-37.60%	-48.25%	-50.60%	0.15	8.03	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$204.55M	-26.40%	-25.60%	-28.62%	-33.40%	0.03	18.38	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$24.51M	-92.40%	-75.70%	-77.48%	3,325.10%	0.18	6.50	100.00%	-304.50%	-303.47%
CVKD	CADRENAL THERAPEUTICS INC	$22.83M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
VSTM	VERASTEM INC	$641.72M	N/A	-159.10%	-204.07%	-526.30%	-12.39	2.58	82.00%	-1,802.10%	-1,786.77%
GHRS	GH RESEARCH PLC	$808.55M	-15.80%	-15.30%	-14.53%	-71.20%	0.04	28.32	N/A	N/A	N/A
OVID	OVID THERAPEUTICS INC	$116.79M	-63.70%	-46.10%	-63.68%	-62.50%	0.43	4.24	100.00%	-549.60%	-549.62%
QURE	UNIQURE NV	$1.22B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
AURA	AURA BIOSCIENCES INC	$415.31M	-69.70%	-58.20%	-62.12%	-82.20%	0.21	9.04	N/A	N/A	N/A
IMTX	IMMATICS NV	$1.22B	-23.30%	-19.10%	-26.21%	-40.90%	0.24	7.36	100.00%	-136.70%	-141.11%
ENVB	ENVERIC BIOSCIENCES INC	$3.24M	-403.40%	-279.50%	-281.40%	1,913.00%	0.26	4.60	N/A	N/A	N/A
ANNX	ANNEXON INC	$594.58M	-93.10%	-72.90%	-111.57%	-120.40%	0.42	4.43	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$27.13M	N/A	-43.70%	-55.18%	-24.10%	-1.81	4.87	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$5.27B	-39.10%	-36.90%	-42.80%	-46.30%	0.07	15.86	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$7.58B	-445.30%	-47.70%	-42.34%	-84.70%	1.42	4.75	89.40%	-113.40%	-97.79%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$920.54M	-42.60%	-13.10%	-11.90%	-16.40%	1.70	5.29	20.90%	-63.10%	-48.76%
OABI	OMNIAB INC	$309.50M	-23.10%	-20.60%	-22.59%	-84.50%	0.12	5.00	98.60%	-301.80%	-317.49%
ANVS	ANNOVIS BIO INC	$109.46M	-153.50%	-125.50%	-184.94%	-8,454.30%	0.31	4.60	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$41.37M	-115.90%	-33.70%	-31.65%	-30.90%	0.40	3.48	100.00%	-346.50%	-220.05%
RVMD	REVOLUTION MEDICINES INC	$15.26B	-49.20%	-40.00%	-47.32%	-46.80%	0.41	8.05	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.57B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
MRNA	MODERNA INC	$11.51B	-31.40%	-24.40%	-30.16%	-30.90%	0.30	3.93	48.30%	-139.60%	-141.26%
NKTR	NEKTAR THERAPEUTICS	$1.11B	-356.80%	-45.20%	-40.25%	-37.00%	2.54	4.24	87.30%	-192.90%	-151.11%
ADTX	ADITXT INC	$1.25M	-757.20%	-156.60%	472.06%	-351.20%	-2.67	0.02	-1,111.20%	-710,498.70%	-703,444.47%
CHRS	COHERUS ONCOLOGY INC	$163.18M	-574.70%	34.90%	115.84%	139.50%	4.89	1.24	47.80%	185.40%	199.92%
IPSC	CENTURY THERAPEUTICS INC	$48.72M	-13.40%	-8.80%	-11.09%	-11.90%	0.39	6.25	100.00%	-23.40%	-21.79%
ATON	ALPHATON CAPITAL CORP	$2.18M	-347.70%	-135.50%	-602.49%	2,165.50%	-24.81	2.02	N/A	N/A	N/A
SRZN	SURROZEN INC	$210.77M	-5,313.30%	-116.50%	-119.80%	-835.10%	-5.00	13.15	100.00%	-6,400.70%	-6,400.73%
NUVL	NUVALENT INC	$7.62B	-39.50%	-35.70%	-42.75%	-44.00%	0.16	10.73	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$2.26B	-20.30%	-7.40%	-9.81%	-7.10%	1.65	2.95	76.30%	-11.20%	-10.45%
CBIO	CRESCENT BIOPHARMA INC	$195.75M	-84.60%	-71.60%	-46.53%	693.40%	0.19	6.63	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$2.78B	-42.90%	-31.50%	-36.74%	-43.30%	0.36	6.02	100.00%	-744.40%	-744.41%
OKUR	ONKURE THERAPEUTICS INC	$41.59M	-95.80%	-86.90%	-121.50%	1,899.00%	0.10	11.45	N/A	N/A	N/A
ACLX	ARCELLX INC	$4.16B	-51.10%	-33.10%	-46.45%	-49.00%	0.49	3.99	100.00%	-607.00%	-695.50%
AIXC	AIXCRYPTO HOLDINGS INC	$12.95M	-90.50%	-65.20%	-19.08%	-420.70%	0.13	8.83	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$160.99M	-77.20%	-62.80%	-102.75%	-117.30%	0.31	4.20	100.00%	-10,069.10%	-10,064.27%
CTMX	CYTOMX THERAPEUTICS INC	$709.93M	44.50%	20.30%	24.11%	60.40%	0.47	3.64	100.00%	24.70%	24.87%
NMRA	NEUMORA THERAPEUTICS INC	$349.22M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
VERU	VERU INC	$35.45M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
ABEO	ABEONA THERAPEUTICS INC	$290.47M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
IFRX	INFLARX NV	$71.13M	-68.50%	-53.20%	-86.90%	-104.20%	0.44	3.33	-8,223.10%	-63,818.90%	-63,757.59%
IMUX	IMMUNIC INC	$74.82M	-716.20%	-252.10%	-969.85%	507.30%	2.88	1.31	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.59B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%
RNAC	CARTESIAN THERAPEUTICS INC	$221.55M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
INO	INOVIO PHARMACEUTICALS INC	$110.36M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
GBIO	GENERATION BIO CO	$36.59M	-94.80%	-34.10%	-62.10%	-34.60%	1.41	4.44	100.00%	-410.10%	-410.13%
NCEL	NEWCELX LTD	$1.21M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
IMNN	IMUNON INC	$12.74M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
RZLT	REZOLUTE INC	$166.91M	-62.80%	-57.10%	-51.99%	-81.70%	0.08	15.15	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.19B	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
ORIC	ORIC PHARMACEUTICALS INC	$913.51M	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$489.01M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$1.32B	-76.10%	-61.70%	-92.76%	-87.80%	0.26	7.18	94.10%	-486.00%	-485.49%
BCAX	BICARA THERAPEUTICS INC	$1.01B	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$429.47M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$43.96M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
CADL	CANDEL THERAPEUTICS INC	$348.60M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$98.29M	-94.90%	-49.30%	-65.03%	-56.80%	1.10	6.74	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$306.98M	-3,645.20%	-133.00%	-127.83%	-149.70%	-36.96	4.27	100.00%	-4,073,233.30%	-4,073,233.33%
BCAB	BIOATLA INC	$48.44M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.47B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
OSRH	OSR HOLDINGS INC	$16.43M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$261.39M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$250.97M	-58.40%	-29.30%	-44.87%	-9,969.30%	1.18	3.36	100.00%	-264.80%	-254.60%
ELAB	PMGC HOLDINGS INC	$2.86M	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
DNLI	DENALI THERAPEUTICS INC	$2.64B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.22B	-389.90%	-153.40%	-263.08%	-206.40%	-24.84	2.86	N/A	N/A	N/A
GNPX	GENPREX INC	$6.45M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$7.75B	N/A	-56.50%	-54.98%	-36.10%	-3.76	6.88	100.00%	-862.20%	-816.07%
SGMT	SAGIMET BIOSCIENCES INC	$202.61M	-42.40%	-40.30%	-48.36%	-70.10%	0.08	13.06	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$64.75M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$3.40B	-46.20%	-43.40%	-54.38%	-55.80%	0.09	12.53	100.00%	-4,084.50%	-4,129.39%
QNCX	QUINCE THERAPEUTICS INC	$234.98M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$83.69M	N/A	-73.40%	-155.14%	-202.80%	-3.40	2.53	100.00%	-205.20%	-202.30%
BMEA	BIOMEA FUSION INC	$99.69M	-310.10%	-145.40%	-241.56%	-1,835.00%	2.53	3.18	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$47.71M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 76.99% over the past year, overperforming other biotech stocks by 122 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 22.51% from Beone Medicines's current stock price of $319.06.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 46, which is 23 points higher than the biotech industry average of 23.

AUPH passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 63.57% over the past year, overperforming other biotech stocks by 109 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $17.25, an upside of 8.83% from Aurinia Pharmaceuticals's current stock price of $15.85.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Aurinia Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.21% over the past year, overperforming other biotech stocks by 56 percentage points.

Innoviva has an average 1 year price target of $32.00, an upside of 55.11% from Innoviva's current stock price of $20.63.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 9 percentage points higher than the biotech industry average of 2.94%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.29%, which is -1 percentage points lower than the biotech industry average of 2.94%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.94%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.42% in the last day, and up 0.28% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the biotechnology industry, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 100.68% in the past year. It has overperformed other stocks in the biotech industry by 146 percentage points.

3. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.21% in the past year. It has overperformed other stocks in the biotech industry by 56 percentage points.

Are biotech stocks a good buy now?

59.96% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 47.94% over the next year.

3.31% of biotech stocks have a Zen Rating of A (Strong Buy), 6.42% of biotech stocks are rated B (Buy), 44.93% are rated C (Hold), 32.3% are rated D (Sell), and 13.04% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 155.66x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Beone Medicines (NASDAQ:ONC)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Innoviva (NASDAQ:INVA)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Innoviva (NASDAQ:INVA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.